About Axter Pharmaceuticals Private Limited
Data last updated:
Axter Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 September 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2014PTC080669. Its GSTIN is 24AAMCA8801E1ZV (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rushikumarkanaiyalal Ribadiya and Sagar Pravinbhai Hirani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 2 1109 Palladium Corporate Road B/H. Divya Bhaskar Makarba, Ahmedabad, Gujarat, India – 380015.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.43 Cr, a growth of 27% compared to the previous year. For the same year it recorded a net profit of ₹4.08 Lakh (net margin 1.2%) and EBITDA of ₹22.59 Lakh (EBITDA margin 6.6%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 3% over five years.
The company is associated with 1 brand: Axter Pharmaceuticals. As per MCA filings, the company has open charges of ₹1.25 Cr and satisfied charges of ₹2.68 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website axterpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressB – 2 1109 Palladium Corporate Road B/H. Divya Bhaskar Makarba, Ahmedabad, Gujarat, India – 380015
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Axter Pharmaceuticals Private Limited
The main business activity of Axter Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Axter Pharmaceuticals Private Limited FY 2025 filings available
Axter Pharmaceuticals Private Limited reported revenue of ₹3.43 Cr (up 27% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Axter Pharmaceuticals Private Limited
Revenue rose 27% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA rose 124% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Axter Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹22.59 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4.08 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Axter Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Axter Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Axter Pharmaceuticals Private Limited
Axter Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Siseken Medicare Private Limited | ₹3.44 Cr (FY 2024) | •••• | •••• | -2.0% | •••• | Meerut, Uttar Pradesh, India |
| Premexa Lifesciences Private Limited | ₹3.43 Cr (FY 2025) | •••• | •••• | 38.0% | •••• | Hyderabad, Telangana, India |
| Reviva Pharmaceuticals India Private Limited | ₹3.43 Cr (FY 2024) | •••• | •••• | -11.0% | •••• | Bangalore, Karnataka, India |
| Jevous Pharmaceuticals Private Limited | ₹3.43 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Raigarh, Maharashtra, India |
| Sucopeia Referencestandards (OPC) Private Limited | ₹3.43 Cr (FY 2024) | •••• | •••• | -11.0% | •••• | Bangalore, Karnataka, India |
| Axter Pharmaceuticals Private Limited this company | ₹3.43 Cr (FY 2025) | •••• | •••• | 27.0% | •••• | Ahmedabad, Gujarat, India |
| Elam Pharma Private Limited | ₹3.42 Cr (FY 2022) | •••• | •••• | -46.0% | •••• | Surat, Gujarat, India |
| Aespire Formulations Private Limited | ₹3.42 Cr (FY 2024) | •••• | •••• | -32.0% | •••• | New Delhi, Delhi, India |
| Allvac Pharmaceuticals Private Limited | ₹3.42 Cr (FY 2025) | •••• | •••• | 79.0% | •••• | Delhi, India |
| Definer Pharmaceuticals Private Limited | ₹3.42 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Lucknow, Uttar Pradesh, India |
| Mangalodayam Pharmaceuticals Private Limited | ₹3.41 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Changaramkulam, Kerala, India |
Peers are the five companies nearest above and the five nearest below Axter Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Axter Pharmaceuticals Private Limited
Axter Pharmaceuticals Private Limited is audited by Pritesh Shah & Co for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Pritesh Shah & Co | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Axter Pharmaceuticals Private Limited
Axter Pharmaceuticals has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rushikumarkanaiyalal Ribadiya | Director | 06 Mar 2020 | 6 Years 7 Months | Current |
| Sagar Pravinbhai Hirani Also directs: Symbiosis Bioscience Private Limited, Symbiosis Biolife LLP | Director | 10 Aug 2024 | 2 Years 1 Months | Current |
| Jagdish Pravinbhai Hirani | Director | 06 Mar 2020 | 6 Years 7 Months | Current |
| Kuldeep Kanaiyalal Ribadiya Also directs: Symbiosis Bioscience Private Limited | Director | 30 Jul 2015 | 11 Years 2 Months | Current |
Ownership and Shareholding of Axter Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Axter Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Apr 2025 | Hdfc Bank Limited | ₹75 Lakh | Open |
| 16 Oct 2015 | Idbi Bank Limited | ₹50 Lakh | Open |
| 19 Dec 2023 | Axis Bank Limited | ₹75 Lakh | Satisfied |
| 07 Dec 2023 | Axis Bank Limited | ₹75 Lakh | Satisfied |
| 04 Aug 2020 | Hdfc Bank Limited | ₹42.5 Lakh | Satisfied |
Total charge records: 7 View all charges
Legal Cases of Axter Pharmaceuticals Private Limited
Axter Pharmaceuticals Private Limited has 2 court cases on record: 2 filed by Axter Pharmaceuticals. All cases are pending. Status as checked on 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Court case (SMST R) | Filed by the company against Rayyan Pharmaceuticals Propreirtor Sowkath Ali Ajmi Suleka | Pending |
| District court, Ahmedabad, Gujarat | Court case (SMST R) | Filed by the company against Rajkumar Agencies Department Chandak Medical Stores | Pending |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Axter Pharmaceuticals Private Limited
Axter Pharmaceuticals operates one associated brand: AXTER PHARMACEUTICALS. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality APIs and finished dosage forms. | axterpharma.com |
Employees and EPFO Compliance at Axter Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Axter Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Axter Pharmaceuticals Private Limited
Axter Pharmaceuticals Private Limited has 10 board changes on record since 2014: 4 appointments and 6 cessations. The latest: Sagar Pravinbhai Hirani was appointed as Director on 10 Aug 2024.
14 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Axter Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Axter Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Axter Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Axter Pharmaceuticals Private Limited
Axter Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAMCA8801E1ZV | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Axter Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Axter Pharmaceuticals Private Limited
Axter Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 September 2014 (12+ years old) and is registered under CIN U24230GJ2014PTC080669.
Axter Pharmaceuticals reported revenue of ₹3.43 Cr for FY 2025 (up 27% YoY).
Axter Pharmaceuticals has 4 current directors:
- Rushikumarkanaiyalal Ribadiya - Director
- Sagar Pravinbhai Hirani - Director
- Jagdish Pravinbhai Hirani - Director
- Kuldeep Kanaiyalal Ribadiya - Director
Axter Pharmaceuticals reported a net profit of ₹4.08 Lakh (net margin 1.2%) and EBITDA of ₹22.59 Lakh (EBITDA margin 6.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Axter Pharmaceuticals is -4% over three years and -3% over five years. In the latest year (FY 2025) revenue rose 27%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Axter Pharmaceuticals is 24AAMCA8801E1ZV, registered in Gujarat.
The CIN (Corporate Identification Number) of Axter Pharmaceuticals is U24230GJ2014PTC080669. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Axter Pharmaceuticals has 2 court cases on record: 2 filed by the company. 2 are pending.
Axter Pharmaceuticals was incorporated on 02 September 2014, making it 12+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Axter Pharmaceuticals by revenue are Siseken Medicare Private Limited, Premexa Lifesciences Private Limited, Reviva Pharmaceuticals India Private Limited, Jevous Pharmaceuticals Private Limited, Sucopeia Referencestandards (OPC) Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Sagar Pravinbhai Hirani was appointed as Director on 10 Aug 2024. Namankumar Kanubhai Trapsia ceased to be Managing Director on 17 Oct 2023. Sagar Pravinbhai Hirani ceased to be Director on 08 Feb 2021. Axter Pharmaceuticals has 10 board changes on record in total.